Literature DB >> 9649225

IL-10 and IL-4 co-operate to normalize in vitro IgA production in IgA-deficient (IgAD) patients.

M Marconi1, A Plebani, M A Avanzini, R Maccario, A Pistorio, M Duse, M Stringa, V Monafo.   

Abstract

In the present study we evaluated in vitro immunoglobulin production from IgAD individuals and healthy controls. Peripheral blood mononuclear cells (PBMC) from IgAD and controls were cultured with anti-CD40 MoAb presented on a CDw32-transfected fibroblast cell line (CD40 system) in the presence of IL-10, IL-2, IL-4, transforming growth factor-beta (TGF-beta) alone as well as of IL-10 in combination with each of the other three cytokines. Only IL-10 added alone induced significant changes in baseline immunoglobulin production; marked increases in median supernatant levels of all three isotypes were observed in both groups. The most striking finding of this study was the synergizing effect of IL-4 on IgA production in the IgAD group when added with IL-10; median IgA supernatant level increased to a value superimposable on that found in the normal controls which remained about the same as when stimulated with IL-10 alone. The synergic effect of IL-4 and IL-10 was specific to the IgA isotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649225      PMCID: PMC1905004          DOI: 10.1046/j.1365-2249.1998.00589.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Defect in IgA secretion and in IgA specific suppressor cells in patients with selective IgA deficiency.

Authors:  T A Waldmann; S Broder; R Krakauer; M Durm; B Meade; C Goldman
Journal:  Trans Assoc Am Physicians       Date:  1976

Review 2.  IgA deficiency.

Authors:  P D Burrows; M D Cooper
Journal:  Adv Immunol       Date:  1997       Impact factor: 3.543

Review 3.  CD40 and its ligand.

Authors:  L B Clark; T M Foy; R J Noelle
Journal:  Adv Immunol       Date:  1996       Impact factor: 3.543

4.  IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency.

Authors:  J Punnonen; L Kainulainen; O Ruuskanen; J Nikoskelainen; H Arvilommi
Journal:  Scand J Immunol       Date:  1997-02       Impact factor: 3.487

5.  Functional assessment of a B cell defect in patients with selective IgA deficiency.

Authors:  J T Cassidy; G Oldham; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

6.  Selective IgA deficiency: presentation of 30 cases and a review of the literature.

Authors:  A J Ammann; R Hong
Journal:  Medicine (Baltimore)       Date:  1971-05       Impact factor: 1.889

7.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

8.  IgA synthesis by peripheral blood mononuclear cells from normal and selectively IgA deficient subjects.

Authors:  M A King; J V Wells; D S Nelson
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

9.  Immature IgA B cells in IgA-deficient patients.

Authors:  M E Conley; M D Cooper
Journal:  N Engl J Med       Date:  1981-08-27       Impact factor: 91.245

10.  Ontogeny of secretory immunity: levels of secretory IgA and natural antibodies in saliva.

Authors:  G R Burgio; A Lanzavecchia; A Plebani; S Jayakar; A G Ugazio
Journal:  Pediatr Res       Date:  1980-10       Impact factor: 3.756

View more
  9 in total

1.  Complexes between nuclear factor-κB p65 and signal transducer and activator of transcription 3 are key actors in inducing activation-induced cytidine deaminase expression and immunoglobulin A production in CD40L plus interleukin-10-treated human blood B cells.

Authors:  S Lafarge; H Hamzeh-Cognasse; Y Richard; B Pozzetto; M Cogné; F Cognasse; O Garraud
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

2.  Central importance of immunoglobulin A in host defense against Giardia spp.

Authors:  T Dianne Langford; Michael P Housley; Marianne Boes; Jianzhu Chen; Martin F Kagnoff; Frances D Gillin; Lars Eckmann
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Route and type of nutrition influence IgA-mediating intestinal cytokines.

Authors:  Y Wu; K A Kudsk; R C DeWitt; E A Tolley; J Li
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

4.  Intracellular cytokine production by Th1/Th2 lymphocytes and monocytes of children with symptomatic transient hypogammaglobulinaemia of infancy (THI) and selective IgA deficiency (SIgAD).

Authors:  D Kowalczyk; J Baran; A D B Webster; M Zembala
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

5.  A case of juvenile idiopathic polyarticular arthritis complicated by IgA deficiency in 22q11 deletion syndrome.

Authors:  Satoshi Sato; Hisashi Kawashima; Kazunori Suzuki; Ryuhei Nagao; Kazumitsu Tsuyuki; Akinori Hoshika
Journal:  Rheumatol Int       Date:  2009-12-11       Impact factor: 2.631

6.  Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency.

Authors:  I R Korponay-Szabó; I Dahlbom; K Laurila; S Koskinen; N Woolley; J Partanen; J B Kovács; M Mäki; T Hansson
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

7.  Mapping of Signaling Pathways Linked to sIgAD Reveals Impaired IL-21 Driven STAT3 B-Cell Activation.

Authors:  Andri L Lemarquis; Fannar Theodors; Helga K Einarsdottir; Bjorn R Ludviksson
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

8.  OVA-Experienced CD4+ T Cell Transfer and Chicken Protein Challenge Affect the Immune Response to OVA in a Murine Model.

Authors:  Ewa Fuc; Dagmara Złotkowska; Ewa Wasilewska; Barbara Wróblewska
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

9.  Transitional B Cells and TLR9 Responses Are Defective in Selective IgA Deficiency.

Authors:  Andri L Lemarquis; Helga K Einarsdottir; Rakel N Kristjansdottir; Ingileif Jonsdottir; Bjorn R Ludviksson
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.